Edition:
India

RaQualia Pharma Inc (4579.T)

4579.T on Tokyo Stock Exchange

2,889JPY
19 Jan 2018
Change (% chg)

¥278 (+10.65%)
Prev Close
¥2,611
Open
¥2,652
Day's High
¥2,889
Day's Low
¥2,610
Volume
3,283,500
Avg. Vol
2,790,017
52-wk High
¥3,170
52-wk Low
¥397

Chart for

About

RaQualia Pharma Inc. is a Japan-based company engaged in the research and development of pharmaceutical products. The Company is mainly engaged in the discovery and research, the preclinical trials and part of clinical trials of drugs, as well as the licensing of developed compounds to pharmaceutical companies. The Company is... (more)
No analyst recommendations are available for .

Overall

Beta: 1.44
Market Cap(Mil.): ¥21,238.53
Shares Outstanding(Mil.): 19.26
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 31.10 16.58
EPS (TTM): -- -- --
ROI: -- 14.84 10.60
ROE: -- 16.32 14.19

BRIEF-RaQualia Pharma to sign license agreements with CJ HealthCare

* Says it plans to sign license agreements with CJ HealthCare regarding RQ-00000004(tegoprazan) and crystal of RQ-00000004(tegoprazan)

28 Dec 2017

BRIEF-RaQualia Pharma signs license agreement with Maruho on selective Na sodium channel blocker

* Says it and Maruho Co Ltd planed to enter into license agreement, regarding selective Na sodium channel blocker, on Dec. 25

25 Dec 2017

BRIEF-RaQualia Pharma ends license agreement related to EP4 antagonist

* Says it ends license agreement with Maruishi Pharmaceutical Co Ltd regarding EP4 antagonist

29 Nov 2017

CORRECTED-OFFICIAL-BRIEF- RaQualia Pharma announces exercise of options

* Says 1,000 units of its 14th series options were exercised to 1 million shares of its common stock, by Daiwa Securities Co. Ltd., during period from Oct. 11 to Oct. 16

16 Oct 2017

BRIEF-RaQualia Pharma says exercise of options

* Says 180 units of its 14th series options were exercised to 180,000 shares of its common stock on Oct. 12

12 Oct 2017

BRIEF-RaQualia Pharma says exercise of options

* Says 100 units of its 14th series options were exercised to 100,000 shares of its stock on Oct. 11, at the price of 998.3 yen per share

11 Oct 2017

BRIEF-RaQualia Pharma confirms to receive upfront payment

* Says it confirms to receive upfront payment from ASAHI KASEI PHARMA CORPORATION

27 Jul 2017

Earnings vs. Estimates